Evidence map›Paper›PMID 31960751›Full record

ArticleJournal of the American Heart Association2020

Contemporary Trends and Outcomes of Percutaneous and Surgical Aortic Valve Replacement in Patients With Cancer.

Avirup Guha, Amit K Dey, Sameer Arora, Matthew A Cavender, John P Vavalle, Joseph F Sabik, Ernesto Jimenez, Hani Jneid, Daniel Addison

Open access · goldAbstract readComparative Study
In one paragraph

Article in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO).European heart journal supplements : journal of the European Society of Cardiology · 2021
    Article
  16. Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond.Journal of the American Heart Association · 2020
    Review
  17. Article
  18. Cardio-Oncology at the Beginning of a New Decade.Journal of the American Heart Association · 2020
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Avirup GuhaHarrington Heart and Vascular Institute Case Western Reserve University Cleveland OH.
Amit K DeyNational Heart, Lung, and Blood Institute Bethesda MD.
Sameer AroraDivision of Cardiology University of North Carolina Chapel Hill NC.
Matthew A CavenderDivision of Cardiology University of North Carolina Chapel Hill NC.
John P VavalleDivision of Cardiology University of North Carolina Chapel Hill NC.
Joseph F SabikDivision of Cardiac Surgery Department of Surgery University Hospitals Cleveland Medical Center Cleveland OH.
Ernesto JimenezDivision of Cardiology Michael E. DeBakey VA Hospital Baylor College of Medicine Houston TX.
Hani JneidDivision of Cardiology Michael E. DeBakey VA Hospital Baylor College of Medicine Houston TX.
Daniel AddisonCardio-Oncology Program Division of Cardiology Ohio State University Columbus OH.
University of North Carolina at Chapel Hill · USMichael E. DeBakey VA Medical Center · USCase Western Reserve University · USNational Heart Lung and Blood Institute · USThe Ohio State University · USUniversity Hospitals of Cleveland · US

Funding

Translational Training Grant in Experimental TherapeuticsK12CA133250 · NCI · OHIO STATE UNIVERSITY · PI WILLIAM E. CARSON, Rosa Lapalombella · 2008 to 2026
$15.0M
NCI NIH HHS K12 CA133250
6 · The paper itself

Abstract

Background Patients with cancer and severe aortic stenosis are often ineligible for surgical aortic valve replacement (SAVR). Patients with cancer may likely benefit from emerging transcatheter aortic valve replacement (TAVR), given its minimally invasive nature. Methods and Results The US-based National Inpatient Sample was queried between 2012 and 2015 using

Indexed as

AgedAged, 80 and overAortic ValveAortic Valve StenosisDatabases, FactualFemaleHeart Valve Prosthesis ImplantationHospital MortalityHumansInpatientsMaleMiddle AgedNeoplasmsOutcome and Process Assessment, Health CarePostoperative ComplicationsRisk Assessmentaortic valve replacementepidemiologyoncologytranscatheter aortic valve

Identifiers

PMID31960751
PMCPMC7033818
OpenAlexW3001318600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.